Trials / Withdrawn
WithdrawnNCT01288625
Prospective Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine
Prospective, Open-label, Randomized, Control Study of Head and Neck Cancer Radiation Treatment With or Without Amifostine
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Sun Pharmaceutical Industries Limited · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the incidence of stomatitis when treating with amifostine before radiation treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amifostine | 500 mg sc, qod, 3 times per week |
| RADIATION | Amifostine | 500mg rinsing wash, qod, 3 times per week |
Timeline
- First posted
- 2011-02-02
- Last updated
- 2021-11-17
Source: ClinicalTrials.gov record NCT01288625. Inclusion in this directory is not an endorsement.